期刊文献+

足细胞损伤与糖尿病肾病 被引量:3

下载PDF
导出
摘要 糖尿病肾病(diabetic nephropathy,DN)是糖尿病的常见微血管并发症,约1/3的糖尿病患者会发展为DN[1]。蛋白尿是DN的特征性标志,虽然DN的病理改变包括肾小球基底膜增厚及系膜增生,但这些变化不能完全解释患者蛋白尿形成的原因。近年来,越来越多的研究发现肾小球脏层上皮细胞(足细胞)损伤参与DN蛋白尿发生,并认为足细胞是糖尿病蛋白尿发生与进展的中心靶点[2]。本文就DN足细胞损伤的研究进展作一综述。
出处 《中国医学前沿杂志(电子版)》 2012年第9期10-14,共5页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 国家自然科学基金(81100478 81270762 30871167)
  • 相关文献

参考文献42

  • 1Farag YM;Al Wakeel JS.Diabetic nephropathy in the Arab Gulf countries[J]NEPHRON CLINICAL PRACTICE,2011(04):c317-c322,c322-c323.
  • 2Ziyadeh FN;Wolf G.Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy[J]Curr Diabetes Rev,2008(01):39-45.
  • 3Kim DK;Nam BY;Li JJ.Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes[J]Diabetologia,2012(04):1205-1217.
  • 4Weil EJ;Lemley KV;Mason CC.Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy[J]Kidney International.
  • 5Gui D;Guo Y;Wang F.Astragaloside IV,a novel antioxidant,prevents glucose-Induced podocyte apoptosis in vitro and in vivo[J]PLoS One,2012(06):e39824.
  • 6Menne J;Meier M;Park JK.Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo[J]Kidney International,2006(08):1456-1462.
  • 7Hsu HH;Hoffmann S;Endlich N.Mechanisms of angiotensin Ⅱ signaling on cytoskeleton of podocytes[J]J Mol Med (Berl),2008(12):1379-1394.
  • 8Cybulsky AV;Kennedy CR.Podocyte Injury Associated with Mutant alpha-Actinin-4[J]J Signal Transduct.
  • 9Pagtalunan ME;Miller PL;Jumping-Eagle S.Podocyte loss and progressive glomerular injury in type II diabetes[J]Journal of Clinical Investigation,1997(02):342-348.
  • 10Mandache E;Penescu M.Nanostructural features of diabetic podocytopathy[J]Romanian Journal of Morphology and Embryology,2012(01):23-27.

二级参考文献10

  • 1Nakamura T,Ushiyama C,Suzuki S,et al.Urinary excretion of podocytes in patients with diabetic nephropathy.Nephrol Dial Transplant,2000,15:1379-1383.
  • 2Hara M,Yanagihara T,Kihara I.Urinary podocytes in primary focal segmental glomerulosclerosis.Nephron,2001,89:342-347.
  • 3Nakamura T,Ushiyama C,Suzuki S,et al.Effects of angiotensin-converting enzyme inhibitor,angiotensin Ⅱ receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.Am J Nephrol,2000,20:373-379.
  • 4Nakamura T,Ushiyama C,Hirokawa K,et al.Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis.Nephrol Dial Transplant,2002,17:798-802.
  • 5Attia DM,Feron O,Goldschmeding R,et al.Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin Ⅱ type 1 receptor-sensitive mechanism.J Am Soc Nephrol,2004,15:949-957.
  • 6Nakamura T,Kawagoe Y,Ogawa H,et al.Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.Am J Kidney Dis,2005,45:48-53.
  • 7Kriz W,Gretz N,Lemley KV,et al.Progression of glomerular diseases:Is the podocyte the culprit? Kidney Int,1998,4:687-697.
  • 8White KE,Bilous RW.Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients.Nephrol Dial Transplant,2004,19:1437-1440.
  • 9Meyer TW,Bennett PH,Nelson RG.Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type Ⅱ diabetes and microalbuminuria.Diabetologia,1999,42:1341-1344.
  • 10李月红,黄海长,刘刚,章友康.检测肾病综合征患者尿中足细胞的临床意义[J].北京大学学报(医学版),2004,36(2):135-138. 被引量:18

共引文献10

同被引文献41

  • 1杨亦彬,张翥,苏克亮,陈泽君,黄颂敏.链脲佐菌素诱导大鼠糖尿病肾病模型的方法学探讨[J].华西医学,2005,20(2):299-300. 被引量:51
  • 2段俊国,廖品正,吴烈,李毓敏,余杨桂,邱波,李传课.中药复方芪明颗粒治疗糖尿病视网膜病变双盲双模拟随机对照多中心临床研究[J].成都中医药大学学报,2006,29(2):1-5. 被引量:74
  • 3高彦彬,赵慧玲,关崧,周晖,庚及娣,谢培风,赵翠芳,商学征,郝青春.糖肾宁治疗气阴两虚、络脉瘀滞型早期糖尿病肾病临床研究[J].中华中医药杂志,2006,21(7):409-411. 被引量:42
  • 4Y Xu, L Wang, J He et al. Prevalence and Control of Diabetesin Chinese Adults [J]. JAMA,2013,310(9) :948-958.
  • 5Lea J, Pnicholas SB. Diabetes mellitus and hypertension: Keyrisk factors for kidney disease[ J]. J Natl Med Assoc,2008,94.
  • 6Dalla VestraM, MasieroA, RoiterAM, et al. Is podocyte injuryrelevant in diabetic nephro-pathy? Studies in patients with type 2diabetes[ J]. Diabetes, 2003 ,52(4) :1031-1035.
  • 7Ziyadeh F N, Wolf G. Pathogenesis of the podocytopathy and pro-teinuria in diabetic glo-merulopathy [ J ]. Curr Diabetes Rec,2008,4(l):39-45.
  • 8刘晓,高媛媛,鲁茜,等.银杏叶提取物、卡托普利和缬沙坦对大鼠糖尿病背病保护作用的比较[J ].中药材,2008,( 1):97-100.
  • 9M. Kestila, U. Lenkkeri and M. Mannikko, et al.,Positionallycloned gene for a novel glomerular protein—nephrin—is mutatedin congenital nephrotic syndrome [J]. Molecular Cell, 1998, 1?4): 575-582.
  • 10F. Bonnet, M. E. Cooper, H. Kawachi, et al. , Irbesartan nor-malises the deficiency in glomerular nephrin expression in a mod-el of diabetes and hypertension[ J]. Diabetologia, 2001,44(7):874-877.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部